Author

Elodie Roger

DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER
DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER

Elodie Roger

IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?
IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?

Elodie Roger

IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?
IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?

Elodie Roger  et al.

ATM-DEFICIENT TUMOR EPITHELIA RESHAPE PANCREATIC CANCER-ASSOCIATED FIBROBLASTS TO FOSTER CANCER AGGRESSIVENESS VIA A DRUGGABLE TGF Β SIGNALING AXIS
ATM-DEFICIENT TUMOR EPITHELIA RESHAPE PANCREATIC CANCER-ASSOCIATED FIBROBLASTS TO FOSTER CANCER AGGRESSIVENESS VIA A DRUGGABLE TGF Β SIGNALING AXIS

Elodie Roger  et al.

MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY
MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY

Elodie Roger

DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER
DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER

MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY
MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY

Elodie Roger  et al.

DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER
DECIPHERING THE MOLECULAR DIALOGUE BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND TUMOR CELLS IN ATM-DEFICIENT PANCREATIC CANCER

Elodie Roger  et al.

IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?
IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?

THE EPIGENETIC FACTOR EZH2 ORCHESTRATES ONCOGENIC FEATURES IN ATM-DEFICIENT PANCREATIC CANCER
THE EPIGENETIC FACTOR EZH2 ORCHESTRATES ONCOGENIC FEATURES IN ATM-DEFICIENT PANCREATIC CANCER

Elodie Roger  et al.

EZH2, AN EPIGENETIC FACTOR INVOLVED IN ONCOGENIC PROPERTIES OF ATM DEFICIENT PDAC SUBTYPES?
EZH2, AN EPIGENETIC FACTOR INVOLVED IN ONCOGENIC PROPERTIES OF ATM DEFICIENT PDAC SUBTYPES?

Elodie Roger

TUMORAL STATUS OF ATM DETERMINES CANCER-ASSOCIATED FIBROBLAST CELL FATE IN PANCREATIC DUCTAL ADENOCARCINOMA
TUMORAL STATUS OF ATM DETERMINES CANCER-ASSOCIATED FIBROBLAST CELL FATE IN PANCREATIC DUCTAL ADENOCARCINOMA

Elodie Roger  et al.

LOSS OF ATM DRIVES NUTRIENT STRESS-INDUCED METABOLIC REPROGRAMMING SUPPORTING PANCREATIC CANCER AGGRESSIVENESS
LOSS OF ATM DRIVES NUTRIENT STRESS-INDUCED METABOLIC REPROGRAMMING SUPPORTING PANCREATIC CANCER AGGRESSIVENESS

Elodie Roger  et al.

EXPLORING ROLES OF ATM-DELETION IN PANCREATIC CANCER VULNERABILITIES AND CANCER-ASSOCIATED FIBROBLAST/TUMOR CELL CROSSTALK
EXPLORING ROLES OF ATM-DELETION IN PANCREATIC CANCER VULNERABILITIES AND CANCER-ASSOCIATED FIBROBLAST/TUMOR CELL CROSSTALK

Elodie Roger  et al.

EZH2, AN EPIGENETIC FACTOR INVOLVED IN ONCOGENIC PROPERTIES OF ATM DEFICIENT PDAC SUBTYPES?
EZH2, AN EPIGENETIC FACTOR INVOLVED IN ONCOGENIC PROPERTIES OF ATM DEFICIENT PDAC SUBTYPES?

Elodie Roger  et al.

ATM DEFICIENCY DRIVES METABOLIC REPROGRAMMING IN PANCREATIC CANCER CELLS
ATM DEFICIENCY DRIVES METABOLIC REPROGRAMMING IN PANCREATIC CANCER CELLS

Elodie Roger  et al.

ATM AND P53 AUTONOMOUS ROLES DURING PANCREATIC CANCER TUMORIGENESIS
ATM AND P53 AUTONOMOUS ROLES DURING PANCREATIC CANCER TUMORIGENESIS

Elodie Roger  et al.

DKK3 IN PANCREATIC CANCER – ELUCIDATING THE ROLES OF A DOUBLE-EDGED SWORD
DKK3 IN PANCREATIC CANCER – ELUCIDATING THE ROLES OF A DOUBLE-EDGED SWORD

Elodie Roger  et al.

REAL-LIFE EXPERIENCE OF PHARMACOTYPING AND RESPONSE PREDICTION USING PANCREATIC CANCER PATIENT-DERIVED ORGANOIDS
REAL-LIFE EXPERIENCE OF PHARMACOTYPING AND RESPONSE PREDICTION USING PANCREATIC CANCER PATIENT-DERIVED ORGANOIDS

Elodie Roger  et al.

COMPARTMENT-SPECIFIC ROLE OF DKK3 IN THE DEVELOPMENT OF PANCREATIC DUCTAL ADENOCARCINOMA
COMPARTMENT-SPECIFIC ROLE OF DKK3 IN THE DEVELOPMENT OF PANCREATIC DUCTAL ADENOCARCINOMA

Elodie Roger  et al.

Item 1 - 20 / 25
1
2